Double Outlet Right Ventricle (DORV) Repair: Surgery, Risks & Recovery | MyMedicPlus — Cost, Top Hospitals & Success Rates | MyMedicPlus

Double Outlet Right Ventricle (DORV) is a rare and complex congenital heart defect in which both of the great arteries — the aorta and the pulmonary artery — arise entirely or predominantly from the right ventricle (RV), rather than the aorta originating from the left ventricle (LV) as in a normal heart. Because the LV has no direct exit, a ventricular septal defect (VSD) is invariably present and serves as the only outlet for oxygenated blood from the LV. The haemodynamic consequences and optimal surgical repair depend critically on the anatomical relationship between the VSD and the great arteries, leading to four principal subtypes: subaortic VSD (most common, ~50%), subpulmonary VSD (Taussig-Bing anomaly, ~25%), doubly committed VSD (~5%), and non-committed (remote) VSD (~20%).

DORV affects approximately 1 in 10,000 live births and accounts for roughly 1–1.5% of all congenital heart defects. It frequently coexists with other structural abnormalities including pulmonary stenosis, atrioventricular septal defects, aortic arch anomalies, and heterotaxy syndromes, making each case anatomically unique and requiring individualised surgical planning. Genetic associations include trisomy 18, deletion 22q11.2 (DiGeorge syndrome), and other chromosomal anomalies; genetic counselling is part of pre-operative workup.

Without surgical correction, the natural history of DORV is universally poor — cyanosis, heart failure, pulmonary hypertension, and death in childhood. With modern open-heart surgical techniques performed at specialised paediatric cardiac centres, outcomes have improved dramatically. Ten-year survival for the most favourable anatomy (subaortic VSD without pulmonary stenosis) exceeds 90% at high-volume centres. Surgery is typically planned during infancy, with the timing dependent on haemodynamic stability, degree of cyanosis, and the presence of associated lesions.

DORV repair addresses the spectrum of anatomical subtypes of this defect and the associated cardiac anomalies that frequently accompany it:

• DORV with subaortic VSD (without pulmonary stenosis): Haemodynamically similar to a large VSD; presents with heart failure and pulmonary overcirculation rather than cyanosis; repaired by intracardiac tunnel (intraventricular repair) directing LV output through the VSD to the aorta
• DORV with subaortic VSD and pulmonary stenosis (Fallot-type DORV): Presents with cyanosis similar to Tetralogy of Fallot; surgical strategy mirrors TOF repair with VSD closure and right ventricular outflow tract reconstruction
• DORV with subpulmonary VSD — Taussig-Bing anomaly: Haemodynamically mimics transposition of the great arteries (TGA); requires arterial switch operation (Jatene procedure) combined with VSD closure for definitive repair
• DORV with doubly committed VSD: The VSD lies immediately beneath both great vessels; tunnel repair to aorta is feasible when the VSD is sufficiently large
• DORV with non-committed (remote) VSD: The most anatomically complex subtype; intracardiac tunnelling may not be possible, necessitating single-ventricle palliation pathway (Fontan circulation) in selected cases
• DORV with atrioventricular septal defect (AVSD): Combined repair of DORV and AVSD in a single operation; technically demanding and associated with higher residual obstruction rates
• DORV with pulmonary atresia: Requires staged repair; initial palliation (systemic-pulmonary shunt or ductus-maintaining prostaglandin) followed by definitive repair with conduit placement

DORV repair is indicated for essentially all patients with this diagnosis, as the natural history without surgery is uniformly fatal. The surgical strategy, timing, and approach are individualised based on a comprehensive pre-operative evaluation:

Pre-operative assessment includes: Transthoracic and transoesophageal echocardiography (the cornerstone of anatomical delineation), cardiac catheterisation with angiography to assess pulmonary artery anatomy and pressures, CT angiography or MRI for 3D anatomical reconstruction especially in complex or heterotaxy cases, and chromosomal/genetic testing.

Timing considerations: Neonates with ductal-dependent circulation or severe haemodynamic compromise may require urgent intervention (prostaglandin infusion to maintain ductal patency followed by early surgery). Haemodynamically stable infants are typically scheduled for elective repair between 3 and 6 months of age before development of irreversible pulmonary hypertension. Infants with DORV and pulmonary stenosis may be managed with palliation (Blalock-Taussig-Thomas shunt) followed by complete repair at 6–18 months. Children presenting late with established pulmonary hypertension require careful catheterisation to assess operability (pulmonary vascular resistance index must typically be below 8 Wood units/m² for biventricular repair to be safe).

Single-ventricle palliation (Glenn and Fontan staging) is reserved for patients in whom biventricular repair is not anatomically achievable, typically those with severely hypoplastic ventricles, complex AVSD, or non-committed VSD not amenable to tunnelling.

Surgical repair of DORV is performed on cardiopulmonary bypass (heart-lung machine) under general anaesthesia through a median sternotomy. The specific operative technique depends entirely on the anatomical subtype:

1. Intraventricular tunnel repair (REV procedure / Kawashima repair): The most commonly applicable technique for subaortic and doubly committed VSD subtypes. A patch-constructed tunnel is fashioned within the right ventricle to channel oxygenated blood from the LV through the VSD to the aorta, physiologically correcting the circulation. If significant right ventricular outflow tract obstruction is present, it is relieved simultaneously with resection of obstructing muscle bundles and/or transannular patch augmentation.

2. Arterial switch operation with VSD closure (for Taussig-Bing DORV): The aorta and pulmonary artery are transected and switched to their normal positions (aorta reconnected to LV, pulmonary artery to RV), with reimplantation of the coronary arteries into the neo-aorta. The VSD is simultaneously closed. This is the definitive repair for the Taussig-Bing anomaly and must be performed within the first 2–4 weeks of life before the LV loses its ability to sustain systemic pressures.

3. Rastelli-type repair (for DORV with subpulmonary stenosis and remote VSD): The VSD is enlarged and a tunnel constructed from LV to aorta; a valved conduit (homograft or xenograft) is interposed between the RV and the pulmonary artery, bypassing the obstructed outflow tract. Conduit replacement is required as the child grows.

4. Single-ventricle palliation pathway: For non-repairable biventricular anatomy. Stage 1: systemic-pulmonary shunt (Blalock-Taussig-Thomas) or pulmonary artery banding; Stage 2: bidirectional Glenn shunt at 4–6 months; Stage 3: Fontan completion at 2–4 years.

Palliative procedures: Pulmonary artery banding (reduces pulmonary blood flow in heart failure) and systemic-pulmonary shunts (augments pulmonary flow in cyanosis) are temporising measures used to stabilise infants before definitive repair.

Successful DORV repair provides life-saving haemodynamic correction with progressively improving long-term outcomes at high-volume centres:

• Survival: Ten-year survival for VSD-type DORV repair exceeds 90% at specialised paediatric cardiac centres; for Taussig-Bing anomaly repaired with arterial switch, early mortality is less than 5% at experienced institutions.
• Correction of cyanosis: Biventricular repair separates pulmonary and systemic circulations, eliminating right-to-left shunting and achieving oxygen saturations above 95% in most patients.
• Resolution of heart failure: Eliminating the intracardiac shunt dramatically reduces volume overload on the right ventricle, resolving or markedly improving congestive heart failure symptoms in the vast majority of infants.
• Near-normal growth and development: Children who undergo successful early repair typically achieve normal growth trajectories, meet developmental milestones, and lead active lives.
• Avoidance of pulmonary hypertensive disease: Early repair before 6 months of age prevents the development of irreversible pulmonary vascular obstructive disease (Eisenmenger syndrome).
• Long-term exercise capacity: Studies show that adults with repaired DORV achieve functional capacity close to age-matched controls, with the majority in NYHA class I or II.

DORV repair is major open-heart surgery with inherent risks that vary with anatomical complexity, patient age and weight, and institutional experience:

• Early mortality: In-hospital mortality ranges from 2–5% for straightforward subaortic VSD repairs to 5–15% for complex subtypes including Taussig-Bing anomaly, AVSD-associated DORV, and single-ventricle palliation at high-volume centres; rates are higher at low-volume institutions.
• Low cardiac output syndrome: Impaired heart function in the immediate post-operative period requiring inotropic support (dopamine, milrinone, epinephrine); managed in the paediatric cardiac ICU.
• Complete heart block: Damage to the conduction system during VSD closure may cause complete heart block requiring permanent pacemaker implantation in 2–5% of cases.
• Residual VSD or outflow tract obstruction: Incomplete closure of the VSD or residual right ventricular outflow tract obstruction may require re-operation; detected by post-operative echocardiography.
• Conduit failure (Rastelli repair): Prosthetic conduits between the right ventricle and pulmonary artery develop stenosis or regurgitation over time and require replacement every 5–15 years as the child grows.
• Coronary artery complications (arterial switch): Coronary transfer during the switch operation carries risk of coronary artery kinking or stenosis, leading to myocardial ischaemia; occurs in approximately 2–5% of cases.
• Neurological injury: Circulatory arrest during surgery and cardiopulmonary bypass carry risk of stroke or neurodevelopmental impairment; modern techniques (selective cerebral perfusion, pH-stat management) minimise this risk.
• Infection: Mediastinitis, sepsis, and endocarditis are serious but uncommon complications managed with targeted antibiotics and, when necessary, re-exploration.

Paediatric cardiac ICU (PCICU): Immediately after surgery, the child is transferred to the PCICU where mechanical ventilation, inotropic support, and continuous haemodynamic monitoring are maintained. Extubation (removal of the breathing tube) typically occurs within 24–72 hours for uncomplicated cases. Chest drains are removed when output is minimal, usually on post-operative day 1–3. PCICU stay averages 3–5 days.

Ward recovery: After PCICU, the child is transferred to the cardiac ward for a further 5–10 days of monitoring, gradual weaning of oral cardiac medications, and assessment of feeding. Wound care and sternal precautions are established during this period. Infants are often discharged on diuretics, ACE inhibitors, and aspirin; medication regimes are adjusted at follow-up visits.

Sternal precautions: The sternum is held together by sternal wires and takes 6–8 weeks to heal fully. During this period, infants and young children should not be lifted by the arms alone; supportive lifting under both arms and the trunk is recommended to avoid sternal stress. Older children should avoid impact sports, swimming, and physical education for 6–8 weeks.

Long-term follow-up: All DORV patients require lifelong cardiology surveillance by a specialist in adult congenital heart disease (ACHD) or paediatric cardiology. Annual echocardiography, periodic Holter monitoring, and exercise stress testing are standard. Patients with conduits (Rastelli repair) require surveillance for conduit failure and planning for transcatheter or surgical replacement. Females reaching reproductive age require specialist pre-pregnancy counselling. Antibiotic prophylaxis for dental and invasive procedures is recommended in patients with residual defects, prosthetic material, or prior endocarditis.

DORV repair is one of the most complex and resource-intensive paediatric cardiac operations. Total costs reflect the surgical complexity, duration of ICU care, specialist team requirements, and post-operative monitoring. Key cost determinants include:

• Anatomical complexity — simple subaortic VSD repair is less costly than Rastelli operation with conduit or arterial switch with VSD closure
• Duration of cardiopulmonary bypass and circulatory arrest — affects operative team time and perfusion consumable costs
• PCICU length of stay — the most variable and significant cost driver; uncomplicated cases average 3–5 days, complex cases may require 2–4 weeks
• Conduit or prosthetic material — homograft valved conduits are expensive; xenograft or synthetic conduits offer cost alternatives
• Re-operations — conduit replacement, pacemaker implantation, or revision of residual defects add substantial costs over the patient's lifetime
• Post-operative medications and outpatient monitoring

Indicative costs by country: USA: USD 80,000–200,000+ (dependent on ICU days and complications). UK (NHS): Funded; private estimate GBP 50,000–120,000. India (top-tier paediatric cardiac centre): USD 8,000–18,000 — representing a 75–85% saving for international families. Thailand and Singapore: USD 15,000–40,000. Many international families choose centres in India (e.g., AIIMS, Amrita, Narayana Hrudayalaya) or Malaysia for DORV repair given the combination of world-class surgical expertise and affordable costs. MyMedicPlus can coordinate referrals to accredited paediatric cardiac centres with documented DORV surgical volumes and outcomes.

True alternatives to surgical repair of DORV are limited because the condition is uniformly fatal without intervention. However, the following management strategies form part of the broader treatment landscape:

• Palliative surgery (staged approach): For complex anatomy not amenable to biventricular repair, staged single-ventricle palliation (Blalock-Taussig-Thomas shunt → bidirectional Glenn → Fontan completion) provides long-term palliation without achieving a biventricular repair; outcomes are inferior to biventricular repair but life-sustaining.
• Pulmonary artery banding: A temporising palliative procedure that reduces pulmonary overcirculation and heart failure symptoms while the child grows to an optimal weight for definitive repair; does not correct the underlying defect.
• Transcatheter interventions: Balloon dilation of pulmonary stenosis or stenting of the ductus arteriosus can stabilise haemodynamics in select cases awaiting surgery. Transcatheter VSD closure is not applicable to the complex intracardiac anatomy of most DORV variants.
• Heart transplantation: Reserved for cases with irreversible ventricular dysfunction after failed repairs or for anatomy not amenable to any form of palliation; limited by donor organ availability, lifelong immunosuppression, and inferior long-term outcomes compared to successful biventricular repair.
• Medical management alone: Diuretics, ACE inhibitors, and digoxin can temporise heart failure symptoms but do not treat the underlying structural defect; used as a bridge to surgery, not as a long-term strategy.